AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation

SAN FRANCISCO, Feb. 26, 2013 /PRNewswire/ -- AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain...

http://feeds.drugs.com/~r/Drugscom-HeadlineNews/~3/uhJR-njeGDM/astrazeneca-annou...

Source: Drugs.com - Pharma News - February 26, 2013 Category: Pharmaceuticals Source Type: news